TTK Healthcare Limited - Asset Resilience Ratio
TTK Healthcare Limited (TTKHLTCARE) has an Asset Resilience Ratio of 71.91% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of TTK Healthcare Limited to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2025)
This chart shows how TTK Healthcare Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see TTKHLTCARE current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down TTK Healthcare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore TTK Healthcare Limited long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs6.01 Billion | 46.38% |
| Short-term Investments | Rs3.31 Billion | 25.53% |
| Total Liquid Assets | Rs9.32 Billion | 71.91% |
Asset Resilience Insights
- Very High Liquidity: TTK Healthcare Limited maintains exceptional liquid asset reserves at 71.91% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
TTK Healthcare Limited Industry Peers by Asset Resilience Ratio
Compare TTK Healthcare Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 5.33% |
|
AbbVie Inc
NYSE:ABBV |
Drug Manufacturers - General | 0.02% |
|
Merck & Company Inc
NYSE:MRK |
Drug Manufacturers - General | 0.22% |
|
AstraZeneca PLC
MX:AZNN |
Drug Manufacturers - General | 0.03% |
|
Novartis AG ADR
NYSE:NVS |
Drug Manufacturers - General | 0.06% |
|
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357 |
Drug Manufacturers - General | 9.91% |
|
Firebrick Pharma Ltd
AU:FRE |
Drug Manufacturers - General | 0.29% |
|
Eli Lilly and Company
SA:LILY34 |
Drug Manufacturers - General | 6.46% |
Annual Asset Resilience Ratio for TTK Healthcare Limited (2005–2025)
The table below shows the annual Asset Resilience Ratio data for TTK Healthcare Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 66.04% | Rs8.46 Billion ≈ $91.50 Million |
Rs12.81 Billion ≈ $138.56 Million |
-3.72pp |
| 2024-03-31 | 69.76% | Rs8.38 Billion ≈ $90.57 Million |
Rs12.01 Billion ≈ $129.84 Million |
-1.80pp |
| 2023-03-31 | 71.56% | Rs8.37 Billion ≈ $90.56 Million |
Rs11.70 Billion ≈ $126.54 Million |
+25.35pp |
| 2022-03-31 | 46.21% | Rs2.58 Billion ≈ $27.92 Million |
Rs5.59 Billion ≈ $60.40 Million |
+2.19pp |
| 2021-03-31 | 44.02% | Rs2.18 Billion ≈ $23.53 Million |
Rs4.94 Billion ≈ $53.45 Million |
+15.28pp |
| 2020-03-31 | 28.74% | Rs1.24 Billion ≈ $13.40 Million |
Rs4.31 Billion ≈ $46.63 Million |
+1.19pp |
| 2019-03-31 | 27.55% | Rs1.15 Billion ≈ $12.39 Million |
Rs4.16 Billion ≈ $44.97 Million |
+5.79pp |
| 2018-03-31 | 21.76% | Rs886.21 Million ≈ $9.58 Million |
Rs4.07 Billion ≈ $44.05 Million |
+19.23pp |
| 2017-03-31 | 2.53% | Rs72.43 Million ≈ $783.27K |
Rs2.86 Billion ≈ $30.98 Million |
-0.82pp |
| 2016-03-31 | 3.35% | Rs101.34 Million ≈ $1.10 Million |
Rs3.03 Billion ≈ $32.72 Million |
+3.30pp |
| 2015-03-31 | 0.05% | Rs1.34 Million ≈ $14.46K |
Rs2.75 Billion ≈ $29.76 Million |
-0.01pp |
| 2014-03-31 | 0.06% | Rs1.34 Million ≈ $14.46K |
Rs2.40 Billion ≈ $25.95 Million |
-0.31pp |
| 2013-03-31 | 0.37% | Rs7.68 Million ≈ $83.07K |
Rs2.09 Billion ≈ $22.64 Million |
-2.80pp |
| 2012-03-31 | 3.17% | Rs67.68 Million ≈ $731.94K |
Rs2.13 Billion ≈ $23.08 Million |
-11.58pp |
| 2011-03-31 | 14.75% | Rs285.40 Million ≈ $3.09 Million |
Rs1.93 Billion ≈ $20.92 Million |
+0.98pp |
| 2010-03-31 | 13.78% | Rs212.75 Million ≈ $2.30 Million |
Rs1.54 Billion ≈ $16.70 Million |
+1.44pp |
| 2009-03-31 | 12.34% | Rs170.43 Million ≈ $1.84 Million |
Rs1.38 Billion ≈ $14.94 Million |
+2.11pp |
| 2008-03-31 | 10.22% | Rs121.77 Million ≈ $1.32 Million |
Rs1.19 Billion ≈ $12.88 Million |
+3.95pp |
| 2007-03-31 | 6.27% | Rs64.73 Million ≈ $700.08K |
Rs1.03 Billion ≈ $11.16 Million |
+1.72pp |
| 2006-03-31 | 4.55% | Rs41.65 Million ≈ $450.47K |
Rs916.13 Million ≈ $9.91 Million |
+0.33pp |
| 2005-03-31 | 4.21% | Rs39.17 Million ≈ $423.56K |
Rs929.63 Million ≈ $10.05 Million |
-- |
About TTK Healthcare Limited
TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, anti… Read more